Magnesium Sulfate and Trigger Points
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: masseter muscle, masseter and sternocleidomastoid muscle.
- Who it may be relevant to
- Registry conditions: Myofascial Pain Syndrome. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Efficacy of Isolated Masseter Versus Masseter- Sternocleidomastoid Trigger Points Injection by Magnesium Sulfate for Myofacial Pain
Overview
The patients will be randomly assigned to one of the two groups according to the treatment method: group I (masseter group) and group II (masseter \&sternocleidomastoid group) where each patient will be injected 0.5ml in each trigger point (TrPs) of magnesium sulphate according to the treatment group by the same operator. The treatment method for TrPs will be the primary predictor variable. Patients will be examined at the following intervals: during diagnosis, 1-month, 3-months, and 6-months post-injection. The participated patients will be assessed using pain score measured on a 10-point visual analogue scale (VAS), the 0 indicating no pain and 10 indicating the worst pain ever
Interventions
- Drug masseter muscle
masseter muscle trigger points injection by magnesium sulphate - Drug masseter and sternocleidomastoid muscle
masseter and sternocleidomastoid muscle trigger points injection by magnesium sulphate
Primary outcome measures
- muscle pain [Time frame: 6 months]
Eligibility criteria
Inclusion criteria
- definite diagnosis of myofascial pain
- presence of one or more unilateral or bilateral trigger points in the masseter muscle and sternocleidomastoid muscle;
- no history of any invasive procedures of the related masseter muscle.
Exclusion criteria
- any painful conditions (other than myofascial trigger points) affecting the orofacial region
- any systemic diseases that could masticatory function (e.g., rheumatoid arthritis and epilepsy);
- pregnancy and lactation
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06975813 · 1111